Robert C. Doebele, University of Colorado (IMAGE)
Caption
Robert C. Doebele, MD, PhD, and colleagues find resistance mechanisms in ALK+ and ROS1+ lung cancers, and demonstrate use to circulating tumor DNA to search for these mechanisms in patient samples.
Credit
University of Colorado Cancer Center
Usage Restrictions
None
License
Licensed content